Skip to main content

Table 3 PFAS concentrations (ng mL−1) measured in serum samples collected from Faroese whaling men (M, n = 10), children (C, n = 51), and women (W, n = 51) between 2004-07

From: Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?

Analyte

Detection Frequency (%)

Median

Range

 

M

C

W

M

C

W

M

C

W

nPFOS

100

100

100

47.8

9.82

5.59

12.66–76.04

4.40–15.0

1.84–13.8

brPFOS

100

100

100

22.4

6.38

3.43

8.13–28.83

3.39–11.6

0.86–9.08

PFHxS

100

100

100

2.38

5.94

0.5

0.53–3.71

3.59–14.3

0.15–1.35

PFUnDA

100

100

100

3.13

0.45

0.28

0.71–6.51

0.05–1.7

0.05–1.06

PFNA

100

100

100

3.76

1.24

0.76

1.14–7.39

0.56–3.58

0.35–2.37

PFOA

100

100

100

3.46

0.73

1.0

2.79–5.36

0.34–1.97

0.35–3.1

PFDA

100

100

100

1.85

0.41

0.32

0.48–2.91

0.15–1.1

0.14–1.06

PFHpS

100

90

86

0.65

0.28

0.09

0.16–1.06

<LOD - 0.65

<LOD - 0.22

PFDoDA

100

20

2

0.27

0.07

0.05

0.06–0.65

<LOD - 0.11

<LOD - 0.05

N-MeFOSAA

100

100

92

0.18

0.18

0.1

0.07–0.38

0.06–0.59

<LOD - 0.21

PFHpA

60

90

6

0.39

0.18

0.05

<LOD - 0.49

<LOD - 0.92

<LOD - 0.12

N-EtFOSAA

90

100

18

0.08

0.43

0.07

<LOD - 0.63

0.06–3.05

<LOD - 0.45

nFOSA

80

14

14

0.08

0.07

0.05

<LOD - 0.34

<LOD - 0.17

<LOD - 0.1

PFDS

60

12

27

0.07

0.04

0.06

<LOD - 0.09

<LOD - 0.05

<LOD - 0.13

brFOSA

90

14

12

0.02

0.02

0.01

<LOD - 0.05

<LOD - 0.03

<LOD - 0.01

15 PFASs

   

87.8

26.2

12.9

26.9–129.1

16.3–39.4

5.01–25.9